يعرض 1 - 10 نتائج من 107 نتيجة بحث عن '"Barry R, Davies"', وقت الاستعلام: 0.70s تنقيح النتائج
  1. 1

    المساهمون: Institut Català de la Salut, [Dunn S] Wellcome Sanger Institute, Cambridge, UK. Bioscience, Early Oncology, AstraZeneca, Cambridge, UK. [Eberlein C, Yelland U] Bioscience, Early Oncology, AstraZeneca, Alderley Park, UK. [Yu J] Wellcome Sanger Institute, Cambridge, UK. Molecular Biology of Metabolism Lab, The Francis Crick Institute, London, UK. [Gris-Oliver A, Serra V] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Ong SH] Wellcome Sanger Institute, Cambridge, UK, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    مصطلحات موضوعية: Cancer Research, Physiological Phenomena::Pharmacological and Toxicological Phenomena::Pharmacological Phenomena::Drug Resistance::Drug Resistance, Neoplasm [PHENOMENA AND PROCESSES], Class I Phosphatidylinositol 3-Kinases, Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES], Medicaments antineoplàstics - Ús terapèutic, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Breast Neoplasms, Antineoplastic Agents, Mechanistic Target of Rapamycin Complex 1, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Phosphatidylinositol 3-Kinases, Cell Line, Tumor, Genetics, Humans, Guanine Nucleotide Exchange Factors, Other subheadings::/therapeutic use [Other subheadings], Protein Kinase Inhibitors, Molecular Biology, Phosphoinositide-3 Kinase Inhibitors, Resistència als medicaments, fenómenos fisiológicos::fenómenos farmacológicos y toxicológicos::fenómenos farmacológicos::resistencia a medicamentos::resistencia a los antineoplásicos [FENÓMENOS Y PROCESOS], neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES], Otros calificadores::/uso terapéutico [Otros calificadores], TOR Serine-Threonine Kinases, PTEN Phosphohydrolase, acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos [COMPUESTOS QUÍMICOS Y DROGAS], Mama - Càncer - Tractament, Female, Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents [CHEMICALS AND DRUGS], Proto-Oncogene Proteins c-akt

    وصف الملف: application/pdf

  2. 2
  3. 3
  4. 4

    المصدر: Nakamura, K, Karmokar, A, Farrington, P M, James, N H, Ramos-Montoya, A, Bickerton, S J, Hughes, G D, Illidge, T M, Cadogan, E B, Davies, B R, Dovedi, S J & Valge-Archer, V 2021, ' Inhibition of DNA-PK with AZD7648 Sensitizes Tumor Cells to Radiotherapy and Induces Type I IFN-Dependent Durable Tumor Control ', Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 27, no. 15, pp. 4353-4366 . https://doi.org/10.1158/1078-0432.CCR-20-3701Test

  5. 5
  6. 6
  7. 7
  8. 8

    المصدر: Nature Communications
    Nature Communications, Vol 10, Iss 1, Pp 1-15 (2019)

  9. 9

    المصدر: Clin Cancer Res

  10. 10